Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
HERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the 'Company' or 'Innocan'), a pharmaceutical technology company focusing on developing innovative drug delivery platform…
BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's What Happened
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) reached a new 52-week high during trading on Friday. The company traded as high as $78.47 and last traded at $78.2370, with a volume of 1972633 shares trading hands. The stock had…
Calamos Advisors LLC Purchases New Shares in Ascendis Pharma A/S $ASND
Calamos Advisors LLC purchased a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 6,450 shares of the…
Braun Stacey Associates Inc. Makes New $18.68 Million Investment in Ascendis Pharma A/S $ASND
Braun Stacey Associates Inc. purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The…
These are Citi's stock picks in its top sectors of the market next year
Citigroup said it saw three areas of the market where investors should pile into next year. The bank's research arm said it was overweight on financials, healthcare, and info tech. The bank also issued a list of top stock picks in each area. The…
Covenant Health says May data breach impacted nearly 478,000 patients
The Covenant Health organization has revised to nearly 500,000 the number of individuals affected by a data breach discovered last May. The healthcare entity initially reported in July that the data of 7,864 people had been exposed, but further…
Advertising Will Boom in 2026, but Hollywood Is at Risk of Being Left Behind
2025 was the year that advertising dealt with shocks to the system: AI disruption reverberated across every part of the ecosystem, Omnicom completed its $13 billion megadeal for IPG, creating a marketing Goliath, and tariff uncertainty threw…
Mystery over husband's death in Israel unsolved, Kerala woman dies by suicide
More than five months after her husband was found dead in Israel, a Kerala woman has ended her life. Reshma, 32, of Kolayadi village in Wayanad, died on Wednesday after allegedly consuming poison. Her husband, Jinesh Sukumaran, 38, worked as a…
Growth Stocks To Consider - January 2nd
Prologis Stock Surges: Why the Rally May Continue Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Canopy Growth are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are…
Global Atlanta's Top 10 Most-Read Stories of 2025
The Belgian American Chamber of the South is the presenting sponsor of Global Atlanta's Belgium Channel. Sign up here for monthly newsletters on Belgian trade and investment connections to Georgia. Busara Advisors is the presenting sponsor of…
Our 2026 Tech Resolutions + We Answer Your Questions
|Our 2026 Tech Resolutions + We Answer Your Questions https://www.nytimes.com/2026/01/02/podcasts/hardfork-tech-resolutions-listener-questions.html This transcript was created using speech recognition software. While it has been reviewed by human…
Fortrea (NASDAQ:FTRE) Shares Down 5.6% - Should You Sell?
Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) shares fell 5.6% during mid-day trading on Friday. The stock traded as low as $16.58 and last traded at $16.2850. 170,352 shares changed hands during mid-day trading, a decline of 87% from the…
First Pacific Financial Increases Stock Position in Novartis AG $NVS
First Pacific Financial boosted its holdings in Novartis AG (NYSE:NVS - Free Report) by 31.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,313 shares…
Generali Asset Management SPA SGR Acquires 6,942 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Generali Asset Management SPA SGR lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 41.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,569…
Coastline Trust Co Sells 3,145 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Coastline Trust Co reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 84.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 597 shares of the pharmaceutical company's…
Receive a Daily briefing on Pharma Industry News
Get Started